PLEASANTON, Calif.--(BUSINESS WIRE)--Calyxo, Inc., a medical device company redefining kidney stone treatment, today highlighted the results from multiple studies presented at the American Urological Association (AUA) 2026 Annual Meeting evaluating the performance of the CVAC System across comparative analyses, benchtop testing, and real-world safety outcomes. Collectively, the data demonstrate consistent stone clearance, high aspiration efficiency, and safety outcomes across a broad range of c
ADVERTISEMENT
ADVERTISEMENT
2026 Copyright © News-Matic.com. All Rights Reserved
